Instinctively, when there are more investigators/sites being deployed for a trial with a defined number of patients needed, we should expect shortened enrollment cycle time. This sounds right, but is it really?
Dr. Gen Li
Advertisement
Dr. Gen Li is president of Phesi. He can be reached at gen.li@phesi.com.
Articles by Dr. Gen Li
Advertisement
Latest Updated Articles
Forecast Enrollment Rate in Clinical TrialsPublished: January 21st 2015 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Confidence Trap in Clinical Trials: When Knowing Just Enough Becomes Dangerous
2
Applied Clinical Trials' 2025 State of the Industry Survey
3
Redefining CRA Workflows Through Intelligent Automation
4
ACT Brief Weekly Recap: Clinical Research Faces Funding Strain, Data Evolution, and a Shift in Outsourcing Models
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
